Fidelity Investments’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205M | Buy |
8,888,742
+4,670
| +0.1% | +$108K | 0.01% | 809 |
|
|
2025
Q1 | $240M | Buy |
8,884,072
+214,131
| +2% | +$5.78M | 0.02% | 731 |
|
|
2024
Q4 | $464M | Buy |
8,669,941
+845,266
| +11% | +$45.3M | 0.03% | 498 |
|
|
2024
Q3 | $355M | Buy |
7,824,675
+47,075
| +0.6% | +$2.14M | 0.02% | 601 |
|
|
2024
Q2 | $326M | Buy |
7,777,600
+28,591
| +0.4% | +$1.2M | 0.02% | 608 |
|
|
2024
Q1 | $292M | Buy |
7,749,009
+3,077,796
| +66% | +$116M | 0.02% | 635 |
|
|
2023
Q4 | $50.1M | Sell |
4,671,213
-1,680,109
| -26% | -$18M | ﹤0.01% | 1290 |
|
|
2023
Q3 | $64M | Buy |
6,351,322
+1,288,526
| +25% | +$13M | 0.01% | 1158 |
|
|
2023
Q2 | $60.1M | Sell |
5,062,796
-77,848
| -2% | -$924K | 0.01% | 1206 |
|
|
2023
Q1 | $62.2M | Sell |
5,140,644
-465,216
| -8% | -$5.63M | 0.01% | 1171 |
|
|
2022
Q4 | $73.8M | Sell |
5,605,860
-641,532
| -10% | -$8.45M | 0.01% | 1088 |
|
|
2022
Q3 | $84.6M | Buy |
6,247,392
+421,688
| +7% | +$5.71M | 0.01% | 1018 |
|
|
2022
Q2 | $71.1M | Buy |
5,825,704
+148,778
| +3% | +$1.82M | 0.01% | 1104 |
|
|
2022
Q1 | $81.4M | Buy |
5,676,926
+685,524
| +14% | +$9.83M | 0.01% | 1164 |
|
|
2021
Q4 | $98.5M | Buy |
4,991,402
+1,375,971
| +38% | +$27.1M | 0.01% | 1111 |
|
|
2021
Q3 | $78.2M | Buy |
3,615,431
+1,771,867
| +96% | +$38.3M | 0.01% | 1212 |
|
|
2021
Q2 | $46M | Buy |
+1,843,564
| New | +$46M | ﹤0.01% | 1471 |
|